| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr2:72105800-72112000 |
Enhancers |
Spleen |
Spleen
|
| 2 |
chr2:72106400-72111600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 3 |
chr2:72106400-72111600 |
Enhancers |
Fetal Muscle Leg |
muscle
|
| 4 |
chr2:72106600-72111800 |
Enhancers |
NHDF-Ad |
bronchial
|
| 5 |
chr2:72106800-72111600 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
| 6 |
chr2:72106800-72111600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 7 |
chr2:72106800-72111600 |
Enhancers |
Right Atrium |
heart
|
| 8 |
chr2:72107000-72111600 |
Enhancers |
HSMM |
muscle
|
| 9 |
chr2:72107200-72111400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 10 |
chr2:72107200-72111400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
| 11 |
chr2:72107200-72111600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 12 |
chr2:72107200-72111600 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
| 13 |
chr2:72107200-72111600 |
Enhancers |
NHLF |
lung
|
| 14 |
chr2:72107200-72111600 |
Enhancers |
Osteobl |
bone
|
| 15 |
chr2:72107400-72111400 |
Enhancers |
Psoas Muscle |
Psoas
|
| 16 |
chr2:72107400-72111600 |
Enhancers |
HMEC |
breast
|
| 17 |
chr2:72107400-72111800 |
Enhancers |
K562 |
blood
|
| 18 |
chr2:72107600-72111600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 19 |
chr2:72107600-72111600 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 20 |
chr2:72109200-72111400 |
Enhancers |
Lung |
lung
|
| 21 |
chr2:72109400-72111600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 22 |
chr2:72109400-72111600 |
Enhancers |
Adipose Nuclei |
Adipose
|
| 23 |
chr2:72109400-72111600 |
Enhancers |
Brain Substantia Nigra |
brain
|
| 24 |
chr2:72109600-72111600 |
Enhancers |
Left Ventricle |
heart
|
| 25 |
chr2:72109600-72111600 |
Enhancers |
Pancreas |
Pancrea
|
| 26 |
chr2:72109600-72112000 |
Enhancers |
Placenta |
Placenta
|
| 27 |
chr2:72109800-72111200 |
Enhancers |
Liver |
Liver
|
| 28 |
chr2:72109800-72111400 |
Enhancers |
Fetal Lung |
lung
|
| 29 |
chr2:72109800-72111600 |
Enhancers |
HUVEC |
blood vessel
|
| 30 |
chr2:72110000-72111600 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 31 |
chr2:72110000-72111600 |
Enhancers |
NH-A |
brain
|
| 32 |
chr2:72110000-72111600 |
Enhancers |
NHEK |
skin
|
| 33 |
chr2:72110200-72111400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 34 |
chr2:72110200-72111400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
| 35 |
chr2:72110400-72111600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 36 |
chr2:72110400-72112800 |
Weak transcription |
Aorta |
Aorta
|
| 37 |
chr2:72110600-72111400 |
Enhancers |
Brain Anterior Caudate |
brain
|
| 38 |
chr2:72110600-72111400 |
Weak transcription |
Esophagus |
oesophagus
|
| 39 |
chr2:72110600-72111400 |
Enhancers |
Fetal Muscle Trunk |
muscle
|
| 40 |
chr2:72110600-72111600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 41 |
chr2:72110600-72115000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 42 |
chr2:72110800-72111200 |
Weak transcription |
Sigmoid Colon |
Sigmoid Colon
|
| 43 |
chr2:72110800-72111400 |
Enhancers |
HepG2 |
liver
|
| 44 |
chr2:72110800-72111600 |
Enhancers |
Brain Cingulate Gyrus |
brain
|
| 45 |
chr2:72110800-72111600 |
Enhancers |
Brain Hippocampus Middle |
brain
|
| 46 |
chr2:72110800-72111600 |
Enhancers |
Brain Inferior Temporal Lobe |
brain
|
| 47 |
chr2:72110800-72111800 |
Enhancers |
A549 |
lung
|
| 48 |
chr2:72111000-72111400 |
Enhancers |
Hela-S3 |
cervix
|
| 49 |
chr2:72111000-72111800 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
| 50 |
chr2:72111000-72111800 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
